The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccesso Technology Group Regulatory News (ACSO)

Share Price Information for Accesso Technology Group (ACSO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 700.00
Bid: 682.00
Ask: 698.00
Change: 24.00 (3.55%)
Spread: 16.00 (2.346%)
Open: 676.00
High: 700.00
Low: 666.00
Prev. Close: 676.00
ACSO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partnership with Henry Ford Health System

1 Mar 2018 07:01

RNS Number : 3132G
Accesso Technology Group PLC
01 March 2018
 

 

01 March 2018

 

 

 

accesso® Technology Group plc

 

("accesso" or the "Group")

 

accesso launches partnership with Henry Ford Health System

 

- Partnership with US Hospital Group brings hospitality insight to the healthcare industry -

 

- The Experience EngineÔ (TE2) to redefine experience for patients, families and caregivers -

 

accesso Technology Group plc (AIM: ACSO), the premier technology solutions provider to leisure, entertainment, cultural and hospitality markets, today announces its first healthcare partnership: a long-term agreement with Henry Ford Health System (HFHS) for the use of TE2, accesso's digital experience and personalisation platform.

 

TE2 will allow HFHS, a six-hospital system headquartered in Detroit, Michigan, to digitise and personalise the entire healthcare journey. accesso's technology will be used to build unique patient profiles which can be easily integrated with electronic medical records, enabling healthcare providers to offer a convenient and frictionless patient experience in real-time, with features such as:

· Concierge service identifying the patient and family by name as they arrive

· Real-time point of care and wayfinding support while inside Henry Ford facilities

· Ability for patients to provide a list of care preferences and to order food during their stay

· Smartphone medical bill payments

· Patient feedback and communication

· Proximity alerts so family members know how their loved one is progressing through an appointment

Henry Ford will pilot the technology beginning in autumn 2018, in preparation for a full multi-phase implementation to coincide with the grand opening of the Brigitte Harris Cancer Pavilion, the new destination centre for the Henry Ford Cancer Institute, expected in 2020. The technology will be available to both patients and caregivers, and the technology and standardisation developed will be made available to other hospitals and health systems throughout the U.S.

Steven N. Kalkanis, M.D., Medical Director, Henry Ford Cancer Institute, and Chair, Department of Neurosurgery, commented:

 

"This is unlike anything we've seen before in healthcare. A cancer diagnosis and everything that comes with it can cause an unspeakable amount of stress for patients and families. A solution of this magnitude has the unparalleled potential to ease that burden and we are thrilled to join with Accesso to create an improved experience for our patients."

 

Spencer Hoover, Henry Ford Health System's Vice President & Executive Director of the Henry Ford Cancer Institute, commented:

 

"We're creating a revolution in healthcare that, for the first time, combines unprecedented convenience with exceptional and personalized care. In Accesso and TE2, we have found committed colleagues that have brought the best of hospitality to healthcare."

 

Steve Brown, CEO of accesso, commented:

 

"Accesso has a long track-record of expanding into new verticals, taking technology that improves user-experience in one area and applying it to others that share similar challenges. We're particularly pleased with this application, not only because we're announcing a partnership in the healthcare space for the first time, but also because our newest technology is enabling us to make a real and meaningful difference to the people's lives at a difficult time."

 

- Ends -

 

For further information, please contact:

 

accesso Technology Group plc

 

 

 

 

+44 (0)118 934 7400

Tom Burnet, Executive Chairman

Steve Brown, Chief Executive Officer

John Alder, Chief Financial Officer

 

FTI Consulting, LLP

+44 (0)20 3727 1000

Matt Dixon, Adam Davidson

 

Canaccord Genuity Limited

+4 (0)20 7523 8000

Simon Bridges, Martin Davison, Richard Andrews

 

Numis Securities Limited

+44 (0)20 7260 1000

Simon Willis, Mark Lander

 

 

About accesso® Technology Group

 

At accesso, we believe technology has the power to redefine the guest experience. Our patented and award-winning solutions drive increased revenue for attraction operators while improving the guest experience. Currently serving over 1,000 clients in more than 30 countries around the globe, accesso's solutions help our clients streamline operations, generate increased revenues, improve guest satisfaction and harness the power of data to educate business and marketing decisions.

 

accesso invests heavily in research and development because our industries demand it, our clients benefit from it and it makes a positive impact on the guest experience.

 

Our commitment to improving the guest experience and helping our clients increase revenue is the core of our business. Our technology solutions allow venues to increase the volume and range of on and off-site spending and to drive increased transaction-based revenue through cutting-edge ticketing, point-of-sale, virtual queuing, distribution and experience management software.

 

Many of our team members come from backgrounds working within the attractions and cultural industry. In this way, we are experienced operators who run a technology company serving attractions operators, versus a technology company that happens to serve the market. Our staff understand the day-to-day operations of managing complex venues and the challenges this creates, and together we strive to provide our clients and their guests with technology that empowers them to do more and enjoy more. From our agile development team to our dedicated client service specialists, every team member knows that their passion, integrity, commitment, teamwork and innovation are what drive our success.

 

accesso is a public company, listed on AIM: a market operated by the London Stock Exchange. For more information, visit www.accesso.com. Follow accesso on Twitter, LinkedIn and Facebook.

 

About TE2 

The Experience Engine™ (TE2) is the leader in experience-driven, personalized advertisement and content delivery for connected consumers, bridging the physical and digital brand experience across mobile, wearables and other digital technologies. TE2 is designed for industries where an in-person experience is a critical engagement opportunity, including hospitality, resorts, theme parks, food, travel, education and health care. For more information about TE2, please visit www.theexperienceengine.com. 

 

About Henry Ford Health System

Henry Ford Health System is a six-hospital system headquartered in Detroit, Michigan. It is one of the nation's leading comprehensive, integrated health systems, recognized for clinical excellence and innovation. Henry Ford provides both health insurance and health care delivery, including acute, specialty, primary and preventive care services backed by excellence in research and education. Henry Ford Health System is led by President & CEO Wright Lassiter III. Visit HenryFord.com to learn more.

About the Henry Ford Cancer Institute

The Henry Ford Cancer Institute is one of the largest cancer programs in Michigan, providing care at five hospitals and six outpatient facilities, and dozens of aligned doctor's offices throughout southeast Michigan. Treatment for the most complex or rare cancers and the Institute's extensive cancer research program is anchored by Henry Ford Hospital. For more information, visit www.henryford.com/cancer.

About Henry Ford Innovations

Established in 2011, Henry Ford Health System Innovations engineers the future of healthcare through identifying and commercializing the health system's technologies and know-how. Its main arms include Research and Education, Technology Management, Corporate Innovation, and International Programs. To learn more, visit HenryFord.com/About/Innovations.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAPAPASXPEFF
Date   Source Headline
3rd May 20244:25 pmRNSDirector/PDMR Shareholding
2nd May 20249:11 amRNSPDMR Notification
2nd May 20247:00 amRNSaccesso Technology Showcase
1st May 20247:00 amRNSTotal Voting Rights
26th Apr 20247:00 amRNSAnnual Report and Notice of AGM
23rd Apr 20247:00 amRNSMello Results Show
23rd Apr 20247:00 amRNSaccesso® Brings ShoWareSM to UK Venues
18th Apr 20247:00 amRNSAdditional Listing
16th Apr 20247:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
5th Apr 20247:00 amRNSHolding(s) in Company
27th Mar 20248:00 amRNSaccesso to Power Saudi Entertainment Destinations
21st Mar 20247:00 amRNSNotice of Results and accesso Technology Showcase
19th Mar 20247:00 amRNSHolding(s) in Company
1st Mar 20247:02 amRNSTotal Voting Rights
1st Mar 20247:01 amRNSDirector/PDMR Shareholding
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSDirector/PDMR Shareholding
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 202410:21 amRNSDirector/PDMR Shareholding
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:01 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTrading Update
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.